Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03194828 · ClinicalTrials.gov registry record · NA
Real-time Glaucoma Medication Adherence
A NA study, sponsored by University of Tennessee.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03194828: Clinical Trial NA study, sponsored by University of Tennessee.
NCT03194828 is a NA study that was terminated before completion, run by University of Tennessee. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03194828, a NA study, was terminated before completion, sponsored by University of Tennessee.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of real-time data collected on patients taking topical medication to treat glaucoma. Patients will be randomized to two groups, the first of which will only use the study device to take their medication, while the second will use the study device and receive on-demand reminder messages, when necessary.
Primary Outcome
Changes and differences in adherence to glaucoma medication between groups
Interventions
- BEHAVIORAL Medication reminder
- BEHAVIORAL Medication monitoring only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-05-08 |
| Est. Completion | 2018-07-15 |
| Phase | NA |
Why NCT03194828 stopped before completion
NCT03194828 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Medication reminder is the first listed.
NCT03194828 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03194828 about?
NCT03194828 is a clinical study titled "Real-time Glaucoma Medication Adherence". This study will evaluate the effectiveness of real-time data collected on patients taking topical medication to treat glaucoma. Patients will be randomized to two groups, the first of which will only use the study device to take their medication, while the second will use the study device and receiv...
What is the current status of trial NCT03194828?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-05-08. Estimated completion is 2018-07-15.
What interventions are being tested in trial NCT03194828?
The interventions under investigation include: Medication reminder (BEHAVIORAL), Medication monitoring only (BEHAVIORAL).
Who is sponsoring clinical trial NCT03194828?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03194828's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI